Centene plans to seek proposals from outside companies to help it manage its more than $30 billion in annual drug spending. Its current PBM contract expires at the end of 2023, according to Bloomberg.
“That’s going to be a huge opportunity for an external PBM,” Drew Asher, Centene’s CFO, said on a call with analysts, Bloomberg reported.
Centene earlier this year recorded a $1.1 billion accounting charge in anticipation of resolving disputes with states that allege the St. Louis-based insurer overcharged their Medicaid programs. It has agreed to pay more than $200 million to resolve claims in Arkansas, Illinois, Ohio and Mississippi and expects to settle more claims, Bloomberg reported. The company has denied any liability.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
